Debunking Myths and Misconceptions of the Psychedelics Industry

As another psychedelic renaissance begins to take flight, it seems that myths and misconceptions rise to meet it. As a molecular pharmacologist studying cannabinoids and psychedelics with training in psilocybin-assisted therapy, I believe it’s vital to dispel these misconceptions. Whether you are a consumer, an investor or simply interested in navigating the chaos that surrounds this burgeoning industry, below are a few mind munchies (aka food for thought) intended to provide some accessible guidance and insight. The topics discussed in this webinar will be regarding the pharmacological history of psychedelics, the varieties of sources of psychedelics, the mechanisms of action of psilocybin and LSD, publicly traded companies in this space, and misconceptions about some of the health outcomes attributed to psychedelics.

Learning Objectives:

1. Summarize the mechanisms of action of psychedelics such as psilocybin and LSD.

2. Discuss the various sources of psychedelics substances, and related environmental issues associated with certain sources.